Holdings
iShares U.S. Healthcare ETF
As of Jul 31, 2026, iShares U.S. Healthcare ETF reported 99 positions worth US$3.55B. Largest: Eli Lilly And Company, Johnson & Johnson and Abbvie Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Eli Lilly And Company | 469K | US$538M | +57,007 | Jul 31, 2026 |
| Johnson & Johnson | 1.41M | US$363M | +178K | Jul 31, 2026 |
| Abbvie Inc. | 1.04M | US$261M | +129K | Jul 31, 2026 |
| Unitedhealth Group Incorporated | 530K | US$220M | +62,505 | Jul 31, 2026 |
| Merck & Company, Inc. | 1.45M | US$189M | +175K | Jul 31, 2026 |
| Thermo Fisher Scientific Inc | 218K | US$125M | +24,193 | Jul 31, 2026 |
| Amgen Inc. | 317K | US$122M | +40,509 | Jul 31, 2026 |
| Abbott Laboratories | 1.02M | US$107M | +128K | Jul 31, 2026 |
| Gilead Sciences, Inc. | 729K | US$94.9M | +89,382 | Jul 31, 2026 |
| Pfizer, Inc. | 3.34M | US$83.6M | +424K | Jul 31, 2026 |